24 research outputs found
Numbers and prevalence for Rapid Diagnostic Test and anti <i>P.falciaprum</i> AMA-1 antibody positive individuals for each sentinel site in Bioko.
<p>Numbers and prevalence for Rapid Diagnostic Test and anti <i>P.falciaprum</i> AMA-1 antibody positive individuals for each sentinel site in Bioko.</p
MOESM1 of Use of mobile technology-based participatory mapping approaches to geolocate health facility attendees for disease surveillance in low resource settings
Additional file 1. Example questionnaire and associated data types
Univariate profile likelihood to evaluate the time at which sero-conversion rates changed.
<p>Same region fits are represented in a) for MSP-1<sub>19</sub> fits and b) for AMA-1. The broken black line is the 95<sup>th</sup> percentile of the Chi-squared on 1 degree of freedom below the maximum. The two points at which this line crosses the log-likelihood profile are used to determine an approximate 95% confidence interval for the time since the change in SCR i.e. 11–18 years for MSP-1<sub>19</sub> and 6 to 14 years for AMA-1. The equivalent plots for Korogwe are shown in c) for MSP-1<sub>19</sub> and d) for AMA-1.</p
Current sero-conversion rates and clinical malaria incidence rates in the IPTi placebo cohort for each health facility: (a) for MSP-1<sub>19</sub> and (b) for AMA-1.
<p>Vertical bars indicate the 95% CI for SCR and horizontal bars indicate the 95% CI for malaria incidence. Fitted lines represent linear regression plots. R<sup>2</sup> values for MSP-1<sub>19</sub> and AMA are 0.78 and 0.91, respectively.</p
Age distribution, RDT positivity and serological responses to both MSP-1<sub>19</sub> and AMA-1 of patients recruited through cross-sectional and health facility surveys in Msitu wa Tembo.
<p>The median titre and interquartile range (IQR) were presented.</p>*<p>denotes a significant difference in the median values tested by ranksum analysis.</p
Age sero-prevalence plots for MSP-1<sub>19</sub> and AMA-1 fitted by maximum likelihood with a single force of infection for the dispensaries in the Kili-IPTi study.
<p>Plot a) MSP-1<sub>19</sub> Same district; b) AMA-1 Same district; c) MSP-1<sub>19</sub> Korogwe district and d) AMA-1 Korogwe district. Black triangles represent observed data and black lines predicted values. Dotted black lines represent upper and lower 95% CI for the predicted SCR.</p
Distribution of study participants by age group, sex, RDT and sero-positivity to both MSP-1<sub>19</sub> and AMA-1 for health facilities in Korogwe and Same districts.
<p>Distribution of study participants by age group, sex, RDT and sero-positivity to both MSP-1<sub>19</sub> and AMA-1 for health facilities in Korogwe and Same districts.</p